Evaluation, Treatment, and Monitoring of Patients With Known or Suspected Parasitic Infection

What this Trial Is About

Researchers are evaluating, treating, and monitoring patients who have known or suspected parasitic infections, including those with malaria, intestinal worms, GI protozoa, echinococcus, and strongyloides. This prospective observational study aims to understand diagnosis, treatment, and disease progression using standard medical practices without experimental treatments. The study is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID). Participants will be grouped based on the type of parasitic infection they have, such as GI parasites, echinococcus, intestinal worms, malaria, or other parasitic infections. Treatment plans are individualized according to each patient's condition and follow standard medical care. The number and length of clinic visits and diagnostic evaluations vary per patient and are determined by the study doctor. During the study, participants will undergo physical exams, medical history reviews, and routine lab tests including blood, stool, and urine samples. Blood draws will be limited to safe amounts based on age and weight. Additional tests may include x-rays, EKGs, or tissue biopsies if needed. Responses to treatment will be assessed at scheduled visits, with timing and total duration personalized to each patient's medical situation. The main outcome measured is the diagnosis, treatment, and understanding of parasitic infections over a one-year period.

Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection